Feasibility Assessment of Zolidd-One-Exhex Dental Implant
Reference number | |
Coordinator | Addbio AB |
Funding from Vinnova | SEK 500 000 |
Project duration | August 2017 - January 2018 |
Status | Completed |
Important results from the project
The aim of the project was to develop a business plan for the continued development of ZoliddOne-Exhex- an implant that fully integrates a nanometre-thin bioactive layer of bonestrengthening pharmaceuticals. We have achieved the project´s goals.
Expected long term effects
The project has accelerated the market penetration and deployment of Zolidd-One-Exhex on the European market, creating a firm basis for establishing European and international brand recognition for the Zolidd® technology and allowing AddBIO to establish itself as the leading provider of bonestrengthening technology for dental implants. The result will be a long-term competitive advantage and potential for growth.
Approach and implementation
The key methods applied in the project included: desk research, analysis of the primary and secondary market data and KOL interviews. The project was divided into three work packages: Strategic Business Review, Business Model Visioning and Business Plan Development and Formulation. The project time was six months.